| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 04/15/2004 | WO2003083063A3 Common ligand mimics: naphtoates |
| 04/15/2004 | US20040073049 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072849 Dioxanes and uses thereof |
| 04/15/2004 | US20040072839 1-Phenylalkylpiperazines |
| 04/15/2004 | US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases |
| 04/14/2004 | EP1406861A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1104750B1 Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives |
| 04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
| 04/14/2004 | CN1488628A Method for preparing lactide |
| 04/14/2004 | CN1145625C Process for the production of tert-buty1 (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2[methyl(methyl sulfonyl)amino]pyrimidin5-yl](4R,65)-2,2-dimethyl[1,3]dioxan-4-yl]acetate ]) |
| 04/14/2004 | CN1145622C Substitated benzo heterocyclic compounds, process for their preparation and pharmaceutical compositions containing same |
| 04/13/2004 | US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) |
| 04/13/2004 | US6720169 By converting the corresponding acetal-protected aldehyde into the corresponding aminonitrile, converting the aminonitrile into the corresponding amino acid amide, and performing enzymatic, enantioselective hydrolysis |
| 04/08/2004 | US20040065866 Low viscosity; solubility at low temperature; low voltage display device |
| 04/07/2004 | EP1405851A1 Method for producing seven-membered diether compounds and intermediates thereof |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404646A2 Process for the preparation of nitrile compounds |
| 04/07/2004 | EP1149087B1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use |
| 04/07/2004 | CN1487929A Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 04/07/2004 | CN1487819A Primary intermediate for oxidative coloration of hair |
| 04/07/2004 | CN1144794C Benzoxazine and benzothiazine derivatives and their application in medicines |
| 04/06/2004 | US6716439 Gels comprising novel fluorinated and alkylated alditol derivatives |
| 04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | WO2004020378A3 Method of producing glycol ethers |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003059874A3 Aromatic thioether liver x-receptor modulators |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 03/31/2004 | EP1403263A1 Process for the preparation of N-(2,3-dihydrobenzo 1,4 dioxin-2-carbonyl) piperazine |
| 03/31/2004 | EP1010425B1 Remedies for irritable bowel syndrome |
| 03/31/2004 | CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713626 Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
| 03/25/2004 | WO2004024677A1 N-hydroxyformamidine derivative |
| 03/25/2004 | WO2004024661A1 Method for producing aldehydes by means of hydroformylation of olefinically unsaturated compounds, said hydroformylation being catalysed by unmodified metal complexes in the presence of cyclic carbonic acid esters |
| 03/25/2004 | WO2003041728A8 Novel phenyl-propargylether derivatives |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | US20040059137 Method for producing compounds having a cf2o bridge |
| 03/25/2004 | US20040059116 Aryl aniline beta2 adrenergic receptor agonists |
| 03/25/2004 | CA2506258A1 Process for preparing aldehydes by hydroformylation of olefinically unsaturated compounds, catalyzed by unmodified complexes of metals of groups 8 to 10 of the pte in the presenceof cyclic carbonic esters |
| 03/25/2004 | CA2498532A1 Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710075 Compounds having a cyclopentabenzofuran core shown to exhibit potent cytotoxic and cytostatic effects on cancer cell growth and viability |
| 03/18/2004 | WO2004022552A1 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | US20040054197 Styrene derivatives and process for production thereof |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/17/2004 | EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| 03/17/2004 | CN1141936C Usage of aryl-cyclohexylamine derivative in anti-disorder of central nervous system |
| 03/16/2004 | US6706744 Hypoglycemic agents; antidiabetic agents |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706715 Reversible inhibitors of the blood clotting enzyme factor viia |
| 03/16/2004 | US6706338 Liquid-crystalline compounds |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004020414A1 Oxytocin inhibitors |
| 03/11/2004 | WO2004020380A1 Method for the hydroformylation of olefinically unsaturated compounds, especially olefins, in the presence of cyclic carbonic acid esters |
| 03/11/2004 | WO2004020378A2 Method of producing glycol ethers |
| 03/11/2004 | WO2003078420A3 Process for making chiral 1,4-disubstituted piperazines |
| 03/11/2004 | WO2003002524A3 Urea derivatives with antiproteolytic activity |
| 03/11/2004 | US20040049057 Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049036 From diphenyl (4-(4-fluorophenyl)-6-isopropyl-2-(methyl-(methyl sulfonyl)amino)pyrimidin-5-ylmethyl)phosphine and tert-butyl-2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl) acetate; removal of tert-butyl group to form acid or salt |
| 03/11/2004 | US20040048894 Compounds which mimic the chemical and biological properties of discodermolide |
| 03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/11/2004 | US20040046150 Liquid-crystalline media comprising at least compound of the formula I and to electro-optical displays containing a liquid-crystalline medium of this type. |
| 03/11/2004 | CA2496887A1 Oxytocin inhibitors |
| 03/11/2004 | CA2496838A1 Process for the hydroformylation of olefinically unsaturated compounds, in particular olefins, in the presence of cyclic carbonic esters |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | CN1480438A Stable ethene in hibitory compound and its prepn method |
| 03/10/2004 | CN1141305C Manufacture of 1, 3-oxathiolane nucleosides |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/04/2004 | WO2004018446A1 Process for the production of ϝ-keto acetals |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | US20040044253 Method of producing glycol ethers |
| 03/04/2004 | US20040044226 Estrogen receptor modulators |
| 03/04/2004 | DE10327435A1 Catalytic hydroformylation of olefins, e.g. internal, highly branched olefins, to aldehydes and alcohols, using unmodified group 8-10 metal, e.g. rhodium, catalyst, is carried out in presence of cyclic (cyclo)alkylene or arylene carbonate |
| 03/04/2004 | DE10327434A1 Verfahren zur Hydroformylierung von olefinisch ungesättigten Verbindungen, insbesondere Olefinen in Gegenwart cyclischer Kohlensäureester A process for the hydroformylation of olefinically unsaturated compounds, in particular olefins in the presence of cyclic carbonic acid ester |
| 03/03/2004 | EP1394157A2 Process for the preparation of 3,5-dihydroxy substituted esters as intermediates for producing optically active 2-(6-(hydroxymethyl)-1,3-dioxan-4-yl) acetic acid dervatives |
| 03/03/2004 | EP1393800A1 Catalyst for carboxylic ester production and process for producing carboxylic ester |
| 03/03/2004 | EP1392656A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF |
| 03/03/2004 | CN1479703A Method for producing compounds having CF2O bridge |
| 03/02/2004 | US6699951 Monomer and polymer for photoresist, photoresist composition, and phosphor layer composition for color cathode ray tube |
| 02/26/2004 | WO2004016213A2 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | CA2495588A1 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1181269B1 Cell proliferation inhibitors |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |